» Articles » PMID: 3146764

Discriminative Stimulus Effects of Caffeine and Benzphetamine in Amphetamine-trained Volunteers

Overview
Specialty Pharmacology
Date 1988 Jan 1
PMID 3146764
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The discriminative stimulus (DS) and subjective effects of caffeine (100 and 300 mg, PO) and benzphetamine (12.5 and 50 mg, PO) were studied in 18 normal human volunteers trained to discriminate between d-amphetamine (10 mg) and placebo. d-Amphetamine increased ratings of drug liking and activity level and produced a profile of subjective effects characteristic of amphetamine and related psychomotor stimulants. The DS effects of d-amphetamine generalized only partially to caffeine and benzphetamine; mean percent d-amphetamine-appropriate responding was 42 and 58 after 100 and 300 mg caffeine, respectively, and 17 and 56 after 12.5 and 50 mg benzphetamine, respectively. Neither dose of caffeine affected ratings of drug liking or activity level, but 300 mg caffeine did produce a profile of subjective effects that partially overlapped with that produced by d-amphetamine. Benzphetamine 50 mg, but not 12.5 mg, increased ratings of drug liking and activity level and produced a profile of subjective effects qualitatively similar to, but weaker than, that produced by d-amphetamine. For both caffeine and benzphetamine, a close relationship was observed between their subjective effects and their ability to substitute for the DS effects of d-amphetamine. These results correspond well with findings obtained from similar studies conducted with laboratory animals, providing further support for the reliability and validity of human drug discrimination paradigms.

Citing Articles

Role of d-amphetamine and d-methamphetamine as active metabolites of benzphetamine: Evidence from drug discrimination and pharmacokinetic studies in male rhesus monkeys.

Banks M, Snyder R, Fennell T, Negus S Pharmacol Biochem Behav. 2017; 156:30-38.

PMID: 28373066 PMC: 5485908. DOI: 10.1016/j.pbb.2017.03.008.


Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans.

Reynolds A, Bolin B, Stoops W, Rush C Behav Pharmacol. 2013; 24(5-6):523-32.

PMID: 23851485 PMC: 4058093. DOI: 10.1097/FBP.0b013e328364505f.


Determining the subjective and physiological effects of BZP combined with TFMPP in human males.

Lin J, Jan R, Lee H, Jensen M, Kydd R, Russell B Psychopharmacology (Berl). 2010; 214(3):761-8.

PMID: 21060995 DOI: 10.1007/s00213-010-2081-7.


Determining the subjective and physiological effects of BZP on human females.

Lin J, Bangs N, Lee H, Kydd R, Russell B Psychopharmacology (Berl). 2009; 207(3):439-46.

PMID: 19777213 DOI: 10.1007/s00213-009-1669-2.


Caffeine reversal of sleep deprivation effects on alertness and mood.

Penetar D, McCann U, Thorne D, Kamimori G, Galinski C, Sing H Psychopharmacology (Berl). 1993; 112(2-3):359-65.

PMID: 7871042 DOI: 10.1007/BF02244933.


References
1.
Evans S, Johanson C . Amphetamine-like effects of anorectics and related compounds in pigeons. J Pharmacol Exp Ther. 1987; 241(3):817-25. View

2.
Goldstein A, KAIZER S, Warren R . Psychotropic effects of caffeine in man. II. Alertness, psychomotor coordination, and mood. J Pharmacol Exp Ther. 1965; 150(1):146-51. View

3.
Chait L, Uhlenhuth E, Johanson C . Reinforcing and subjective effects of several anorectics in normal human volunteers. J Pharmacol Exp Ther. 1987; 242(3):777-83. View

4.
Chait L, Uhlenhuth E, Johanson C . The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology (Berl). 1986; 89(3):301-6. DOI: 10.1007/BF00174364. View

5.
Chait L, Evans S, Grant K, Kamien J, Johanson C, Schuster C . Discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology (Berl). 1988; 94(2):206-12. DOI: 10.1007/BF00176846. View